Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value
Diagnostyka Laboratoryjna · 29.06.2026 · 62 (3) · 195-203
DOI: 10.5604/01.3001.0055.8710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostyka Laboratoryjna, erschienen am 29.06.2026. Verfasst von Piotr Łojko und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Introduction
Myocardial injury is a frequent complication of COVID-19 and
is associated with worse clinical outcomes. While cardiac troponins have
been extensively studied, the clinical significance of creatine kinase (CK) and
creatine kinase–myocardial band (CK‑MB) in COVID‑19 remains less clearly
defined.
Aim
The aim of this systematic review was to critically evaluate the available
evidence regarding the diagnostic and prognostic significance of CK and CK-MB
in patients with COVID-19.
Materials and methods: A systematic review of the literature was conducted
in accordance with the PRISMA 2020 statement to evaluate the association
between CK‑related biomarkers and myocardial injury, disease severity, and
mortality in patients with COVID‑19. Due to the limited number of eligible
studies and heterogeneity in study design and outcome reporting, findings
were synthesized qualitatively.
Results
Four eligible studies evaluating CK and CK‑MB in hospitalized
COVID‑19 patients were identified. Across these studies, elevated CK or CK‑MB
levels were consistently associated with markers of myocardial injury and with
indicators of more severe disease. These biomarkers may therefore provide
additional information for risk stratification in COVID‑19.
Conclusions
CK and CK‑MB are widely available laboratory markers that
may assist in identifying myocardial injury and increased disease severity
in COVID‑19. Further prospective studies are required to clarify their prognostic
value and potential role in clinical decision‑making.
Zitieren
APA
Łojko, P., & Wierzbicka-Rucińska, A. (2026). Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value. Diagnostyka Laboratoryjna, 62(3), 195-203. https://doi.org/10.5604/01.3001.0055.8710
Vancouver
Łojko P, Wierzbicka-Rucińska A. Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value. Diagnostyka Laboratoryjna. 2026;62(3):195-203. doi:10.5604/01.3001.0055.8710
BibTeX
@article{ojko2026,
author = {Łojko, Piotr and Wierzbicka-Rucińska, Aldona},
title = {Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value},
journal = {Diagnostyka Laboratoryjna},
year = {2026},
volume = {62},
number = {3},
pages = {195--203},
doi = {10.5604/01.3001.0055.8710}
}
EUVIMED